E-mail a Wiley Online Library Link

Mariana Chavez-MacGregor, Jennifer Litton, Huiqin Chen, Sharon H. Giordano, Clifford A. Hudis, Antonio C. Wolff, Vicente Valero, Gabriel N. Hortobagyi, Melissa L. Bondy and Ana Maria Gonzalez-Angulo Pathologic complete response in breast cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy Cancer 116

Version of Record online: 19 AUG 2010 | DOI: 10.1002/cncr.25296

Among 2074 breast cancer patients treated with anthracycline- and taxane-based neoadjuvant chemotherapy, race/ethnicity was not found to be significantly associated with pathologic complete response rates. Improved outcomes were observed in Hispanics and a trend toward worse outcomes in black patients, when compared with whites.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field